Literature DB >> 15922062

Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.

Ruxandra Iancu1, Paul Mohapel, Patrik Brundin, Gesine Paul.   

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Several toxin-induced animals models simulate the motor deficits occurring in PD. Among them, the unilateral 6-hydroxydopamine (6-OHDA) model is frequently used in rats and has the advantage of presenting side-biased motor impairments. However, the behavioral consequences of a unilateral 6-OHDA-lesion have, so far, not been described in detail in mice. The aim of this study was to characterize mice with unilateral 6-OHDA-lesions placed in the median forebrain bundle using several motor behavioral tests in order to identify the most suitable predictor of nigral cell loss. Mice underwent various drug-induced (amphetamine- and apomorphine-induced rotation) and spontaneous motor tests (cylinder, rotarod, elevated body swing, and stride length test). The amphetamine-induced rotation test, the cylinder and the rotarod test were most sensitive and reliable in detecting loss of tyrosine hydroxylase-immunoreactive cells in the substantia nigra. This study demonstrates that substantial and stable unilateral 6-OHDA-induced lesions can be established in mice, and that these lesions can be functionally assessed using several different side-bias-based behavioral tests. This mouse model offers the opportunity to use transgenic mouse strains and study the interactions between genes of interest and toxins in relation to Parkinson's disease etiology in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922062     DOI: 10.1016/j.bbr.2005.02.023

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  109 in total

1.  Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.

Authors:  Sherri L Thiele; Ruth Warre; Joanne E Nash
Journal:  J Vis Exp       Date:  2012-02-14       Impact factor: 1.355

2.  The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.

Authors:  Alin Ciobica; Zenovia Olteanu; Manuela Padurariu; Lucian Hritcu
Journal:  J Physiol Biochem       Date:  2011-10-18       Impact factor: 4.158

3.  Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

Authors:  Marine Hovakimyan; Stefan Jean-Pierre Haas; Oliver Schmitt; Bernd Gerber; Andreas Wree; Christian Andressen
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

4.  Dissociable effects of disconnecting amygdala central nucleus from the ventral tegmental area or substantia nigra on learned orienting and incentive motivation.

Authors:  Heather El-Amamy; Peter C Holland
Journal:  Eur J Neurosci       Date:  2007-03       Impact factor: 3.386

5.  Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.

Authors:  Mahboubeh Manouchehrabadi; Mona Farhadi; Zahra Azizi; Anahita Torkaman-Boutorabi
Journal:  Neurotox Res       Date:  2019-07-30       Impact factor: 3.911

6.  Therapeutic cloning in individual parkinsonian mice.

Authors:  Viviane Tabar; Mark Tomishima; Georgia Panagiotakos; Sayaka Wakayama; Jayanthi Menon; Bill Chan; Eiji Mizutani; George Al-Shamy; Hiroshi Ohta; Teruhiko Wakayama; Lorenz Studer
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

7.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

8.  Quantifying muscle alterations in a Parkinson's disease animal model using electromyographic biomarkers.

Authors:  Pablo Y Teruya; Fernando D Farfán; Álvaro G Pizá; Jorge H Soletta; Facundo A Lucianna; Ana L Albarracín
Journal:  Med Biol Eng Comput       Date:  2021-07-23       Impact factor: 2.602

9.  Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease.

Authors:  Li Gao; Hua She; Wenming Li; Jin Zeng; Jinqiu Zhu; Dean P Jones; Zixu Mao; Guodong Gao; Qian Yang
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

10.  Parvalbumin+ and Npas1+ Pallidal Neurons Have Distinct Circuit Topology and Function.

Authors:  Arin Pamukcu; Qiaoling Cui; Harry S Xenias; Brianna L Berceau; Elizabeth C Augustine; Isabel Fan; Saivasudha Chalasani; Adam W Hantman; Talia N Lerner; Simina M Boca; C Savio Chan
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.